AVTX-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVTX-002, covering 2024-09-05 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. [Phase 2]